Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Moodys
McKesson
Mallinckrodt
McKinsey

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for L-Citrulline


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug L-Citrulline?

L-Citrulline is an investigational drug.

There have been 22 clinical trials for L-Citrulline. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2006.

The most common disease conditions in clinical trials are Hypertension, Anemia, Sickle Cell, and Syndrome. The leading clinical trial sponsors are Asklepion Pharmaceuticals, LLC, Vanderbilt University, and Vanderbilt University Medical Center.

Recent Clinical Trials for L-Citrulline
TitleSponsorPhase
Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesDuke UniversityPhase 2
Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesNational Heart, Lung, and Blood Institute (NHLBI)Phase 2
Supplementing L-citrulline to Overweight Late Asthma oNset PhenotypesNational Institutes of Health (NIH)Phase 2

See all L-Citrulline clinical trials

Clinical Trial Summary for L-Citrulline

Top disease conditions for L-Citrulline
Top clinical trial sponsors for L-Citrulline

See all L-Citrulline clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Moodys
McKesson
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.